Immix Biopharma, Inc. (IMMX) Stock Overview
Explore Immix Biopharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Immix Biopharma, Inc. (IMMX)
Key Financials
Key Financials
Market Cap
460.8M
P/E Ratio
-9.16
EPS (TTM)
$-0.92
ROE
-0.73%
IMMX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Immix Biopharma, Inc. (IMMX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 45.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.99.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.16 and a market capitalization of 460.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.